Showing 1 - 20 results of 116 for search '"Pfizer"', query time: 0.06s Refine Results
  1. 1

    New-Onset Lichen Planus Induced by the Pfizer COVID-19 Vaccine by Fadi A. Alghamdi, Shahad T. Khayyat, Mohammed M. Alshareef, Wala’a Felemban

    Published 2022-01-01
    “…New-onset lichen planus appeared 48 hours after the first dose of the Pfizer vaccine. The symptoms worsened following the second dose. …”
    Get full text
    Article
  2. 2

    Liver Functions in Type 2 Diabetes Individuals after Pfizer Vaccination in Iraqi Patients by Shrooq Ali Hussein, Ahmed Abdul-Hussein Mohsin, Ahmed Ghazi Sabbar

    Published 2022-09-01
    “…The current research concludes that there is no effect of the Pfizer vaccine on a biochemical parameter of the liver. …”
    Get full text
    Article
  3. 3
  4. 4

    A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination by Yaritza Serrano Gomez, Brittney Grella, Hongbei Wang

    Published 2022-01-01
    “…We present a case of an 81-year-old male evaluated in the emergency department for a bilateral purpuric non-blanching rash that appeared ten days after receiving the Pfizer-BioNTech booster vaccine against SARS-CoV-2. …”
    Get full text
    Article
  5. 5
  6. 6

    Comparison of IgG and Neutralizing Antibody Response After Pfizer BioNTech COVID-19 Vaccine Among Iraqi Individuals by Najat Saeed Hussein, Izzat Abdulsatar Al-Rayahi, Salwa S. Muhsin, Redhwan Abdul Kareem Alameer

    Published 2023-06-01
    “…A total of 41 vaccinated individuals with Pfizer-BioNTech COVID-19 vaccine, as well as (10) non vaccinated were included in the study.   …”
    Get full text
    Article
  7. 7
  8. 8
  9. 9

    Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series by Maris Taube, Maris Taube, Alise Alma Lesiņa

    Published 2025-01-01
    “…This article describes three patients who reported anxiety after receiving a complete course of the Pfizer-BioNTech BNT162b2 vaccine. It is important to explore the relationship between anxiety, other mental health disorders, and COVID-19 vaccination, as well as to investigate potential pathogenetic mechanisms.…”
    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13

    Favorable Nonclinical Safety Profile of RSVpreF Bivalent Vaccine in Rats and Rabbits by Jun Zhou, Christopher J. Bowman, Vicki R. Markiewicz, Balasubramanian Manickam, Emily Gomme, Rani S. Sellers, Cynthia M. Rohde

    Published 2024-12-01
    “…<b>Background</b>: Respiratory syncytial virus (RSV) infections usually cause mild, cold-like symptoms in most people, but are a leading infectious disease causing infant death and hospitalization and can result in increased morbidity and mortality in older adults and at-risk individuals. Pfizer has developed Abrysvo<sup>®</sup>, an unadjuvanted bivalent recombinant protein subunit vaccine containing prefusion-stabilized fusion (F) proteins representing RSV A and RSV B subgroups (RSVpreF). …”
    Get full text
    Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20